Add Formweb to your mobile device
Search results for:
ustekinumab
ustekinumab
Brand names: Imuldosa, Otulfi, Pyzchiva, Selarsdi, Stelara, Stelara PFS, Steqeyma, Wezlana, Yesintek
| Form | Strength | ANAN | ASMP | LACH | LALK | LOHH | LOLR | LOWC | SDSD | SESE | SFSF | Formulary Status |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SOLUTION, INTRAVENOUS | 5 mg/mL; aauz 5 mg/mL; aekn 5 mg/mL; auub 5 mg/mL; kfce 5 mg/mL; srlf 5 mg/mL; stba 5 mg/mL; ttwe 5 mg/mL | Restricted to outpatient use only | ||||||||||
| SOLUTION, SUBCUTANEOUS | 45 mg/0.5 mL; 90 mg/mL | Restricted to outpatient use only |
Last updated: Oct. 15, 2025
- Therapeutic Interchange: Biosimilar and Reference Products Conversion List for Adults
- Restricted: Restricted to outpatient use only
- CMS Self-Administered Drug Exclusion List Stelara (subcutaneous only)
Medications Approved for Automatic Therapeutic Interchange Dosage Conversion Guidelines
(Note: “Therapeutic Interchange” should be placed in the order comments)
Biosimilar and Reference Products Interchange List for Adults
Medication
Reference Drug or Biosimilar
Formulary Status
Automatic Therapeutic Interchange
Inpatient1
Outpatient
*New Starts/New Authorizations Only*
Stelara (brand) or generic ustekinumab
Reference
Formulary, restricted to OP (preferred)
NFT approval is needed
Use Stelara (brand or generic) unless third party payer requires other ustekinumab product
Wezlana (ustekinumab-auub)
Pyzchiva (ustekinumab-ttwe)
Selarsdi (ustekinumab-aekn)
Steqeyma (ustekinumab-stba)
Yesintek (ustekinumab-kfce)
Otulfi (ustekinumab-aauz)
Imuldosa (ustekinumab-srlf)
Starjemza (ustekinumab-hmny)
Biosimilars
Formulary, restricted to OP
(not preferred)
Interchange to Stelara (brand or generic) unless third party payer requires other ustekinumab product